Project Details
Description
MT2020-36: A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes (TILs) in Subjects with Advanced Melanoma
| Status | Active |
|---|---|
| Effective start/end date | 10/28/20 → 10/31/25 |
Funding
- INSTIL BIO, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.